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Structure, Regulation, and Function of 
Protein Tyrosine Phosphatases 
N.K. ToNgs, Q. YANG, AND P. GUIDA, JR. 
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 
The phosphorylation f tyrosyl residues in proteins is 
an essential aspect of many signal transduction events, 
including the control of both normal and neoplastic cell 
growth and proliferation. Since the earliest observa- 
tions of tyrosine phosphorylation, it has been ap- 
preciated that this is a reversible process in which the 
net level of phosphate in a target substrate reflects the 
balance between the competing action of kinases and 
phosphatases. Thus, in cells transformed by tempera- 
ture-sensitive mutants of Rous sarcoma virus, an eleva- 
tion in the levels of phosphotyrosine is observed at the 
permissive temperature, atwhich the kinase is active; 
however, if the cells are shifted to the nonpermissive 
temperature, at which the kinase is inactivated, a rapid 
dephosphorylation of tyrosyl residues ensues due to the 
action of protein tyrosine phosphatases (PTPases) (Sef- 
ton et al. 1980). The last 10 years has witnessed great 
progress in the characterization f the protein tyrosine 
kinases, whereas the PTPases, although equally im- 
portant, remained relatively neglected until recently. It 
is now apparent hat the PTPases constitute a large, 
structurally diverse family of both nontransmembrane 
and receptor-linked, transmembrane proteins. In this 
paper, we review briefly some of the recent progress in 
the characterization of the structure, function, and 
mode of regulation of the PTPases. 
Structural Diversity of Members 
of the PTPase Family 
An enzyme referred to as PTP1B was the first 
tyrosine phosphatase to be isolated in homogeneous 
form (Tonks et al. 1988a,b). Determination of its 
amino acid sequence revealed twostriking observations 
(Charbonneau et al. 1988). First, it is not structurally 
related to the Ser/Thr-specific protein phosphatases. 
Thus it appears that, unlike the kinases which are all 
derived from a common ancestor, the phosphatases 
have evolved in separate families. Second, however, a
striking homology was detected between PTP1B and 
each of the tandem repeated intracellular domains of 
the leukocyte common antigen, CD45. CD45 is a trans- 
membrane protein expressed exclusively on hemato- 
poietic cells (Thomas 1989). Its structure can be de- 
scribed in terms of an intraceUular segment, comprising 
two PTPase-related domains, a single transmembrane 
sequence, and an extracellular segment that bears the 
hallmarks of a ligand-binding motif. Thus, the exciting 
Cold Spring Harbor Symposia on Quantitative Biology, Volume LVI. 9 1991 Cold Spring Harbor Laboratory Press 0-87969-061-5/91 $3.00 
possibility was raised that CD45 may be regarded as a 
prototype for a novel family of receptor-linked mole- 
cules with the potential to initiate signal transduction 
pathways via the ligand-modulated dephosphorylation 
of tyrosyl residues in proteins. This was strengthened 
by the subsequent confirmation that CD45 displays 
intrinsic PTPase activity (Tonks et al. 1988c). Follow- 
ing these observations, many different PTPase isoforms 
have been described in a wide variety of tissues and cell 
lines (Fig. 1). 
More than ten distinct ransmembrane PTPases have 
now been identified by various cloning strategies 
(Streuli et al. 1988, 1989; Kaplan et al. 1990; Kreuger 
et al. 1990; Matthews et al. 1990; Gebbink et al. 1991). 
With the exception of HPTPfl (Kreuger et al. 1990), 
which bears a single catalytic domain, the intracellular 
segments of the receptors are very similar, comprising 
two PTPase-related omains. The functional signifi- 
cance of such an arrangement remains unclear. Obvi- 
ously, oligomeric enzymes have the inherent capacity 
for cooperative interactions between the catalytic cen- 
ters; however, suggestions have been made that only 
the amino terminal of the two PTPase-related domains 
is active (Streuli et al. 1990). Interestingly, in domain II 
of receptor PTPases T and ~ (according to Streuli et al. 
1990), the conserved active site cysteine residue de- 
scribed below is replaced by aspartate, suggesting that 
at least in these enzymes, this domain may not be 
catalytic. Nevertheless, it remains a possibility that the 
second domain may have a distinct specificity from the 
first with its substrates yet to be identified, or even that 
it may be modulated specifically by ligands. Preliminary 
observations by at least one group indicate a low level 
of activity in the isolated second domain of RPTPa in 
vitro (Wang and Pallen 1991). Although the intracellu- 
lar segments of the various receptor PTPases are close- 
ly related, they diverge in their extracellular segments, 
a feature that presumably indicates a similarly diverse 
array of ligands. Although CD45 may be regarded asa 
prototype receptor-linked PTPase, as expected, the 
other members of the family are not restricted in their 
expression to hematopoietic cells. LAR, which is ex- 
pressed in a variety of tissues, displays structural simi- 
larity to the N-CAMs in its extracellular segment, com- 
prising 3 immunoglobulin-like and 8 fibronectin type 
III-like domains. HPTPfl has the longest extracellular 
segment identified thus far, comprising 16 repeated 
fibronectin type III domains (1599 residues), whereas 
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Figure 1. Structural organization of protein tyrosine phosphatases. Conserved catalytic domains are shown in black. The PTPases 
can be categorized as transmembrane, receptor-like, or non-transmembrane molecules. The receptor-like species can be 
subdivided into four types based on the structure of their extracellular segments. Type I represents he CD45 family, multiple 
isoforms of which arise from differential splicing of a primary mRNA transcript of a single gene; three exons encoding sequences 
at the extreme amino terminus (horizontal shading) are differentially expressed. Type II, containing immunoglobulin-like 
(diagonal lines) and fibronectin type Ill-like (stippled) domains, includes LAR, DLAR, DPTP, and HPTP~. Type III bear 
multiple fibronectin type III repeats, uch as in HPTPfl, which is also characterized bythe presence of only one PTPase domain in 
its intracellular segment. Type IV, such as a and e, have very small, glycosylated extracellular segments. Multiple non- 
transmembrane forms have also been identified. In TCPTP and PTB1B, and carboxy-terminal oncatalytic segment appears to 
play a role in modulating activity and controlling subcellular localization. Several PTPases bearing noncatalytic amino-terminal 
segments have now been identified. These segments include two SH2 domains in PTP1C, a band 4.1 homology domain in PTPH1, 
and structures apparently unrelated to sequences in the data base in STEP, PYP1, and YOP2b. The vaccinia protein VH1 is 
smaller than the other PTPase-related segments and presumably encodes only a catalytic domain. This is not an exhaustive list and 
the family continues to expand. A number of partial cDNAs for additional PTPases have also been identified but are not included. 
the very short external domains of HPTPa and 9 com- 
prise only 123 and 27 residues, respectively. It is tempt- 
ing to speculate that LAR may participate in adhesion 
reactions through homophilic interactions between the 
extracellular segments of these molecules on adjacent 
cells. Interestingly, the receptors for a number of solu- 
ble low-M r factors have been shown to contain fibro- 
nectin type I I I  "modules" (Norton et al. 1990; Patthy 
1990). Although these structures may simply be indica- 
tive of segments important in protein:protein ter- 
action, one could also speculate that the activity of 
HPTP/3 may be influenced by soluble ligands or even 
members of the integrin family. At present, we still 
await data to suggest he identity of PTPase ligands. 
In the initial flurry of activity concerning the identifi- 
cation of novel PTPases, the receptor-linked forms pre- 
dominated. Now a diverse array of nontransmembrane 
PTPases have also been identified. The cDNA for a 
PTPase closely related to PTP1B was isolated originally 
from a human peripheral T-cell library (Cool et al. 
1989). This molecule, TCPTP, is now known to display 
a broad tissue distribution. Comparison of these two 
sequences with those of CD45 and LAR revealed a 
conserved segment of approximately 230 residues, 
which most likely represents the catalytic domain and 
has been found in all the PTPases identified sub- 
sequently (Charbonneau et al, 1989). Within this con- 
served domain is a common cysteinyl residue that is 
essential for activity, explaining the sensitivity of these 
enzymes to thiol-directed reagents. The sequence sur- 
rounding this cysteine, [ I /V]HCXAGXXR[S/T]G,  is 
highly conserved, representing the signature motif that 
characterizes members of this family. Guan and Dixon 
(1990), on searching the NBRF data base, observed 
this motif in the Yop2b protein of the pathogenic bac- 
terium Yersinia and the VH1 protein of the pox virus, 
vaccinia (Guan et al. 1991a). In both cases, the authors 
have demonstrated phosphatase activity intrinsic to the 
protein. In fact, for Yersinia, which is the causative 
agent of the plague or Black Death, the PTPase activity 
of the Yop protein is essential for virulence. In a 
murine macrophage cell line-model system, Yop2b pro- 
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motes the dephosphorylation of proteins of 120 kD and 
60 kD, the identities of which remain to be established 
(Bliska et al. 1991). 
The first nontransmembrane PTPases described, the 
low-M r enzymes PTP1B and TCPTP, display a similar 
structural organization--the catalytic domain is situ- 
ated in the amino-terminal portion of the molecule, 
and the carboxy-terminal segment serves a regulatory 
function (Cool et al. 1990). However, in many of the 
more recent additions to the family, the PTPase do- 
main is carboxy-terminal, whereas the amino terminus 
is noncatalytic. Several groups have isolated cDNAs for 
a PTPase in which the large noncatalytic amino ter- 
minus contains two adjacent SH2 (Src homology region 
2) domains (Shen et al. 1991). SH2 domains are found 
in several cytoplasmic proteins that serve a signaling 
function, including phospholipase-C3,, GAP, PI3 ki- 
nase, and several protein tyrosine kinases, including src 
itself, and are involved in binding to tyrosine phosphor- 
ylated proteins (Koch et al. 1991). Whether they serve 
to target his PTPase to specific substrates or to mod- 
ulate phosphatase activity remains to be established. In
addition, a PTPase which in its amino-terminal segment 
displays identity to the cytoskeletal-associated proteins, 
band 4.1, ezrin, and talin, has been identified and is 
described in detail below (Yang and Tonks 1991). Fur- 
thermore, the Yop proteins from Yersinia (Guan and 
Dixon 1990), a molecule termed PYP1 from Schizosac- 
charomyces pombe (Ottilie et al. 1991), and STEP, 
isolated as a neural-specific eDNA from a rat striatal 
library (Lombroso et al. 1991), all contain amino- 
terminal segments that are not related to sequences in
the data base and whose function remains to be estab- 
lished. An additional PTPase comprising essentially a 
catalytic domain alone has also been identified in Sac- 
charomyces cerevisiae (Guan et al. 1991b). 
At present, little is known about many of these 
PTPases except for their structure; in fact, for several, 
intrinsic activity remains to be established. The next 
goals will involve progressing beyond structure to 
characterize the activity, substrate specificity, mode of 
regulation, and, thus, physiological function of these 
enzymes. 
Regulation of PTPase Activity 
In vitro, when assayed with artificial substrates, 
PTP1B as isolated from human placenta displays a 
submieromolar K m and a very high specific activity, 
some 1-3 orders of magnitude in excess of that of the 
PTKs (Tonks et al. 1988b). Similar levels of activity 
against an appropriate substrate were observed in prep- 
arations of CD45 (Tonks et al. 1990). These features 
suggest hat the PTPases will effectively modulate the 
level of cellular phosphotyrosine. Furthermore, one 
would anticipate that the activity of the PTPases must 
be tightly regulated so as to permit he normal function 
of the PTKs. The mechanisms by which this is achieved 
are now beginning to come to light. 
For the receptor PTPases there is the potential for 
control of activity through interaction with ligands. It 
remains unclear as to exactly what would be the effect 
of ligand binding. If the high basal activity of CD45 
toward phosphotyrosyl myelin basic protein (MBP) is a 
general feature of receptor PTPases and is also ob- 
served with physiologically relevant phosphotyrosyl 
proteins within the cell, then it seems unlikely that the 
binding of ligands to the extracellular portion would 
enhance activity further. It is possible that in the basal 
condition only one of the two PTPase domains is active 
and the second becomes activated upon ligand inter- 
action. Alternatively, the function of ligands may be to 
inhibit activity or perhaps even to control the localiza- 
tion of the PTPase on the surface of the cell, thus 
modulating the activity by restricting the spectrum of 
proteins with which it can interact. 
The nontransmembrane enzyme, PTPIB, was puri- 
fied from human placenta as a monomeric atalytic 
subunit of 37 kD (Tonks et al. 1988a). However, when 
cDNAs for this enzyme were isolated, they were ob- 
served to encode a molecule of approximately 50 kD 
that bore an extension of about 11 kD at the carboxyl 
terminus (Brown-Shimer et al. 1990; Chernoff et al. 
1990; Guan et al. 1990). Similarly, the eDNA for a 
closely related molecule (74% identity in the catalytic 
domain), termed TCPTP, also encodes a48-kD PTPase 
with a carboxy-terminal extension relative to the 
placenta enzyme (Cool et al. 1989). Thus, it now ap- 
pears that PTP1B was isolated originally as a truncated 
species, although whether or not this truncation repre- 
sents a physiologically relevant processing event re- 
mains to be established. 
The properties of the 48-kD form of TCPTP were 
investigated following its expression in BHK cells 
(Cool et al. 1990). It was found to be associated with a 
particulate fraction isolated by low-speed centrifuga- 
tion of a cell extract; solubilization of the PTPase re- 
quired treatment with detergent. When the detergent 
lysate was subjected to gel filtration, the PTPase was 
recovered in a very high M r complex, eluting essentially 
in the void volume of a Superose 12 column. Perhaps 
most importantly, when activity in the lysates was as- 
sayed with reduced carboxamidomethylated and 
maleylated (RCM) tysozyme, the expressed enzyme 
displayed little activity unless first subjected to limited 
trypsinization. This proteolytic activation was accom- 
panied by the removal of the carboxy-terminal t il to 
generate a molecule of approximately 33kD. When a 
truncated 37-kD form of the enzyme, in which the 
carboxy-terminal segment was deleted by insertion of a 
premature stop codon, was expressed, it was found to 
be no longer exclusively particulate, no longer associ- 
ated with a high-M r complex, and now spontaneously 
active toward RCM lysozyme. Similarly, when both 
48-kD and 37-kD forms were xpressed in Sf9 cells 
using the baculovirus system and purified to 
homogeneity, the truncated species displayed a very 
high activity toward RCM lysozyme, whereas the full- 
length form was relatively inactive unless first subjected 
to limited trypsinization (Zander et al. 1991). Interest- 
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ingly, the full-length enzyme was also activated by 
MBP and displayed a potent activity toward phos- 
photyrosyl MBP in the absence of trypsin. It would 
appear that the carboxy-terminal segment of TCPTP 
plays a role both in modulating the activity of the 
catalytic domain and in controlling the localization of 
the enzyme within the cell. 
When BHK cells are stimulated with platelet-derived 
growth factor (PDGF), the phosphorylation f tyrosyl 
residues in several proteins is induced. When this pat- 
tern is compared to that induced by PDGF in BHK 
cells expressing either the 48-kD or 37-kD forms of 
TCPTP, both forms of the phosphatase lead to a reduc- 
tion in the level of phosphotyrosine (Cool et al. 1990). 
Thus, there are mechanisms within the cell to permit 
the manifestation of the activity of the full-length 
TCPTP. Comparison of the maximal levels of PTPase 
activity detectable in extracts of BHK cells expressing 
either the 48-kD or 37-kD forms of TCPTP indicated 
that the cell can tolerate much higher levels of the 
full-length form of the enzyme than the truncated. In 
addition, expression of the 37-kD form induces ignifi- 
cant aberrations in the cell cycle not seen with the 
full-length enzyme (D.E. Cool et al., in prep.). The 
37-kD-expressors develop amultinucleated phenotype, 
apparently due to a defect in cytokinesis. Furthermore, 
in the resulting syncytial cells, the nuclei divide asynch- 
ronously. Within a single cell, one could detect nuclei 
in interphase together with nuclei n mitosis, suggesting 
that the phosphatase disrupted the signals which main- 
tain nuclear synchronization. The nature of the sub- 
strates involved in these effects remains unclear; how- 
ever, these data further attest o the importance of the 
carboxy-terminal segment of TCPTP in the capacity of 








Figure 2. Structural features of the carboxy-terminal segment 
of TCPTP. The bar depicts the earboxy-terminal segment of 
TCPTP schematically, indicating the position of the putative 
nuclear localization signal (residues 377-381) as well as the 
position and sequence of the hydrophobic carboxyl terminus 
of the molecule (residues 396-415). The hydrophobicity of
residues in this segment is plotted with positive numbers on 
the y - axis indicative of a hydrophobic nature and negative 
numbers representing hydrophilic sequences. (Reprinted, 
with permission, from Cool et al. 1990.) 
The structure of the carboxy-terminal segment of 
TCPTP is summarized in Figure 2. The hydrophobicity 
plot indicates that this segment ispredominantly h dro- 
philic, whereas the last 19 residues are hydrophobic and 
may contribute to the particulate localization of the 
48-kD protein. A similar distribution of charged and 
hydrophobic residues is seen in the carboxy-terminal 
segment of PTPIB. The degree of conservation of se- 
quence in these segments i much less than in the core 
catalytic domain; however, they are related, perhaps 
indicative of a general function in regulating activity 
and localization. Motifs within such segments, which 
are unique to a particular isoform, may point to specific 
roles for that enzyme. For example, the hydrophobic 
carboxyl terminus of TCPTP is preceded by a stretch of 
basic residues that possess the features of a nuclear 
localization signal (Cool et al. 1990). Whether it func- 
tions as such remains to be established. Clearly, it will 
be important o identify the putative targeting and 
regulatory proteins with which these low-M r PTPases 
interact. The characterization f such interactions may 
illustrate a new tier of control of the level of cellular 
phosphotyrosine. 
A general theme is becoming apparent among the 
family of PTPases. Distinct structural motifs within the 
molecule may control activity through interaction with 
targeting or regulatory proteins. Superimposed on this 
is the growing realization that the PTPases are them- 
selves phosphoproteins. CD45 is known to be phos- 
phorylated on Ser/Thr residues in vitro (Tonks et al. 
1990) and in vivo (Autero and Gahmberg 1987). In 
fact, stimulation of lymphocytes with phorbol ester 
alters the surface distribution of CD45 (Patarroyo and 
Gahmberg 1984). In recent studies, it has also been 
shown that stimulation of Jurkat T cells with anti-CD3 
antibodies or the mitogenic lectin phytohemagglutinin 
induces phosphorylation of tyrosyl residues in CD45 
(Stover et al. 1991). The regulatory significance of this 
remains unclear. Although it may not affect activity 
directly, it may be of importance in controlling pro- 
cesses such as the redistribution f CD45 that accom- 
panies T-cell activation (Minami et al. 1991). Phos- 
phorylation of nontransmembrane PTPases on seryl, 
threonyl, and tyrosyl residues has also been observed 
(N.K. Tonks et al., unpubl.). It has recently been 
reported that stimulation of cAMP-dependent protein 
kinase or PKC led to an enhanced PTPase activity in 
the particulate fraction in various cell lines, although 
the precise mechanism of this effect remains to be 
elucidated (Brautigan and Pinault 1991). 
Physiological Substrates for the PTPases 
For a protein to be a substrate for a phosphatase, it 
must first have been phosphorylated bya kinase. Thus, 
the identification of the substrates for the tyrosine ki- 
nases and phosphatases ssentially simplifies to the 
same problem. Many PTK substrates are only recog- 
nized by their apparent M r on SDS gels, and the search 
for physiological substrates whose function is altered 
following tyrosine phosphorylation remains a major 
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goal of research in this area. Purified preparations of
CD45 will dephosphorylate and inactivate phos- 
photyrosyl-MAP kinase in vitro (Anderson et al. 1990). 
Similarly, phosphotyrosyl-PLC3, is dephosphorylated 
and inactivated by TCPTP (Nishibe et al. 1990). These 
examples illustrate that the PTPases represent useful 
probes to discern the role of tyrosine phosphorylation, 
if any, in modulating the activity of a particular en- 
zyme. However, the results do not necessarily reflect 
the specificity of the PTPases in vivo. 
One approach to identifying the physiological role of 
CD45 has involved the generation of CD45-negative 
cells. Although one such T-ceU line which is defective 
in surface expression of CD45 failed to respond to 
antigen or cross-linked CD3 but still proliferated in 
response to IL2, a CD45 § revertant displayed the nor- 
mal proliferative response to antigen and cross-linked 
CD3 (Pingel and Thomas 1989). Further experiments 
by Koretzky et al. (1990) have shown that CD45- 
HPB-ALL cells fail to generate phosphatidylinositol 
(Ptdlns)-derived second messengers orelevate intracel- 
lular Ca ++ in response to stimulation of the T-cell 
receptor. This was not due to a defect in the Ptdlns 
turnover pathway itself, and the response to T-cell 
receptor stimulation could be restored by transfecting 
back cDNA encoding CD45. Similarly, in CD45-defi- 
cient Jurkat cells, signaling through the T-cell receptor 
and CD2 is abrogated, including the stimulation of 
PTK activity (Koretzky et al. 1991). These observa- 
tions are important because they highlight he fact that 
CD45 may play a positive role in stimulating signal 
transduction events--thus, the PTPases hould not be 
viewed simply as providing an "off-switch" to counter 
the activity of PTKs. The identity of the substrates 
involved remains to be established, but the products of
the lck and fyn genes, members of the src family of 
PTKs, are likely candidates. These kinases possess a 
site of tyrosine phosphorylation in their carboxyl ter- 
minus that is inhibitory (for review, see Eisenman and 
Bolen 1990); dephosphorylation of this site by CD45 
would be expected to activate the kinase. There is 
already circumstantial evidence to implicate p56 ~k as a 
substrate for CD45 (Ostergaard et al. 1989; Mustelin 
and Altman 1990). These cell lines not only represent a 
powerful tool to identify the substrates for CD45, but 
also provide a model system with which to analyze 
structure/function relationships in this receptor- 
PTPase. 
A tyrosine-phosphorylated protein that represents a 
major focus of effort in the context of this meeting is 
the eukaryotic cel! cycle regulator, p34 r In G 2 phase 
of the cell cycle, p34 cdc2 is phosphorylated ona tyrosyl 
residue in the ATP-binding site, and its activity is sup- 
pressed. Dephosphorylation f p34 ~dr activates it as a 
histone H1 kinase and drives the cell from G 2 into 
mitosis (for review, see Lewin 1990). Consequently, 
the PTPase that depbosphorylates p34 r is a key ele- 
ment in the control of the cell cycle, and its identifica- 
tion and characterization will be an essential step to- 
ward our understanding of this process. 
The timing of mitosis depends on a regulatory net- 
work of genes that act through p34 r162 The inhibitory 
pathway contains the niml, weel, and mikl gene prod- 
ucts, which are protein kinases (Lundgren et al. 1991). 
In addition, there is a stimulatory pathway that con- 
tains p80 coo:5 (Russell et al. 1989). Strains of S. pombe 
bearing a temperature-sensitive mutation in cdc25, 
termed cdc25-22, arrest in G 2 at the restrictive tem- 
perature with p34 r phosphorylated on tyrosyl res- 
idues. Upon returning to the permissive temperature, 
there is dephosphorylation f p34 cdc2, and the cells 
advance into mitosis (Gould and Nurse 1989). Arrest at 
the restrictive temperature can be bypassed by expres- 
sion of a form of p34 cdc2 in which the phosphorylated 
tyrosine has been mutated to phenylalanine (Gould 
and Nurse 1989) or by expression of the PTPase, 
TCPTP (Gould et al. 1990). In both cases, the cells 
advance prematurely into mitosis at a reduced cell size, 
the "wee" phenotype, and in the case of expression of 
TCPTP, this correlates with the dephosphorylation of 
tyrosyl residues in p34 cdr Thus, p80 cdc25 is intimately 
associated with the dephosphorylation and activation of 
p34 cdr but is it a PTPase? 
Following the identification by Guan et al. (1991a) of 
the vaccinia virus protein VH1 as a distant relative of 
the PTPases, many investigators detected a somewhat 
limited structural similarity between VH1 and p80 cdc25 
(Moreno and Nurse 1991). Although it will dephos- 
phorylate and activate p34 cde2 directly in vitro (Straus- 
feld et al. 1991), VH1 appears to display a restricted 
substrate specificity (of the substrates tested, only 
p34 r itself is dephosphorylated at a significant rate) 
and poor catalytic efficiency relative to TCPTP. How- 
ever, given the distant relationship between p80 ~dc25 
and the other PTPases, it is entirely possible that the 
former utilizes a different catalytic mechanism, perhaps 
involving a stoichiometric association with the substrate 
p34 cdc2. Alternatively, an activating component may be 
missing in these in vitro reactions. Whereas in S. pombe 
dephosphorylation f Y15 in p34 r162 is sufficient for 
activation, in higher eukaryotes the adjacent threonyl 
residue, T14, is also phosphorylated (for review, see 
Lewin 1990). Thus, under these conditions, activation 
of p34 edc2 should require ither the coordinate action of 
tyrosine-specific and threonine-specific phosphatases or 
the action of a single broad specificity enzyme with the 
capacity to dephosphorylate both tyrosyl and threonyl 
residues. Interestingly, unlike the previously character- 
ized FrPases, VH1, to which p80 ~dr shows most simi- 
larity, displays dual specificity in vitro (Guan et al. 
1991a). Whether p80 r162 functions as such in vivo re- 
mains to be established. 
Identification of Novel PTPase lsoforms 
In our laboratory, we have utilized a PCR-based 
strategy to identify the complement of PTPases in 
HeLa cells. Multiple PTPase-related sequences were 
amplified from a HeLa cell cDNA library including the 
known enzymes PTP1B, TCPTP, receptor PTPa, and 
LAR. In addition, three distinct PTPases were iden- 
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tiffed, two receptor-like molecules and a nontransmem- 
brane PTPase (Yang and Tonks 1991) whose structure 
suggests it will be important in the control of cyto- 
skeletal function (Fig. 3). 
The latter cDNA encodes aprotein of approximately 
104 kD termed PTPH1, which can be described in 
terms of three segments: (1) The amino-terminal seg- 
ment displays homology with amino-terminal domains 
in the cytoskeletal-associated proteins, ba d 4.1, talin, 
and ezrin; (2) the central segment did not show homol- 
ogy to sequences in the data base but did bear a number 
of putative phosphorylation sites for Ser/Thr kinases, 
including casein kinase II and p34Cdc2; (3) the segment 
displaying homology with members of the PTPase fami- 
ly is located at the carboxyl terminus. It should be 
noted that cDNA for a closely related PTPase was also 
isolated recently b  another group (Gu et al. 1991). In 
collaboration with D.E. Hill and A. Bruskin, PTPH1 
has now been expressed in BSC40 cells using the vac- 
cinia virus expression system, and intrinsic PTPase ac- 
tivity has been demonstrated (N.K. Tonks et al., un- 
publ.). In a manner similar to the low-M, enzymes 
PTP1B and TCPTP, activity against RCM lysozyme is 
stimulated by limited trypsinization, whereas the en- 
zyme dephosphorylates MBP without prior proteolysis. 
Amino acid and cDNA sequence analyses previously 
defined a family of proteins that encompassed band 4.1 
(Conboy et al. 1986), talin (Rees et al. 1990), and ezrin 
(Gould et al. 1989; Turunen et al. 1989). In erythro- 
cytes, band 4.1 promotes the association f actin and 
spectrin aod through its amino-terminal segment inter- 
acts with the transmembrane protein glycophorin (Ben- 
nett 1989). Thus, it acts as a linker to anchor the 
cytoskeleton to the plasma membrane. Similarly, talin 
interacts with the transmembrane extracellular matrix 
(ECM) receptor, integrin. Ezrin displays a submem- 
braneous localization in brush border cells, but the 
details of its interaction with other proteins remain to 
be established. Nevertheless, the homologous domain 
of approximately 340 residues at the amino terminus of 
these molecules appears to define a family of proteins 
that are targeted to the interface between the plasma 
membrane and the cytoskeleton. Therefore, we pro- 
pose that PTPH1 will display a similar localization. 
Again, PTPH1 appears to be illustrative of the general 
theme among members of the PTPase family; distinct 
structural motifs within the protein may, at least in 
part, control specificity by restricting intracellular 
localization. 
Transformation by oncogenic protein tyrosine ki- 
nases such as src is accompanied by dramatic altera- 
tions in cellular morphology; the cells assume a round- 
ed, less adherent phenotype. This is associated with a 
disruption of the actin cytoskeleton and a reduction in 
the number of cell:cell and cell:substratum contacts 
(Kellie et al. 1991). Cells in culture adhere to the 
external substrate through specialized regions of the 
plasma membrane termed focal adhesion plaques. 
Within focal adhesions, the integrins provide the trans- 
membrane link between the ECM and the cytoskeleton 
(Burridge et al. 1988). Their intracellular segments 
interact with actin through a multiprotein complex 
comprising talin, vinculin, a actinin, and undoubtedly 
other components yet to be described. Similar but less 
well characterized structures have been implicated in 
points of cell:cell contact. A contributing factor to the 
generation of the transformed phenotype is the phos- 
phorylation of tyrosyl residues in several focal contact 
proteins including vinculin, talin, ezrin, paxillin, and 
the /3 subunit of integrin (Kellie et al. 1991). Con- 
nexin43 in adherens junctions has also recently 
been identified as a substrate for src (Swenson et al. 
I I~ t CD45 





If I PTPH1 
I I I Human band 4.1 
37% 
I I ~ Human ezrin 
27% 
I I ........ I I Mouse taiin 
20% 
Figure 3. Structural organization of PTPH1. Shaded boxes denote the homologous segments in PTPH1 and the cytoskeletal- 
associated proteins, band 4.1, ezrin, and talin, which may direct these proteins to the interface between the plasma membrane and 
the cytoskeleton. The PTPase domains are shown in black. Homology among domains is dicated by the percentage identity. 
(Adapted from Yang and Tonks 1991.) 
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1990). The exact role of tyrosine phosphorylation i
generating the transformed morphology remains un- 
clear, although the phosphorylation f integrins may be 
crucial (Horvath et al. 1990). Immunocytochemical 
staining with antibodies to phosphotyrosine has indi- 
cated that phosphorylation of tyrosyl residues in focal 
adhesion and apical junction proteins also occurs in 
nontransformed cells (Maher et al. 1985), suggesting 
that PTKs, as yet to be identified, act on these sites 
during normal cell function. In view of the disastrous 
effects of aberrant tyrosine phosphorylation, one would 
anticipate that the activity of these PTKs will be tightly 
controlled. The localization of a PTPase to these struc- 
tures is one means by which such regulation may be 
achieved. Studies are currently in progress to ascertain 
whether PTPH1 may serve such a role. 
If PTPH1 is targeted to structures such as focal adhe- 
sion plaques, one would anticipate that following over- 
expression, it may be able to antagonize the action of 
src. PTPH1 was expressed constitutively from an LTR 
promoter in src-transformed NIH-3T3 cells. The ex- 
pression vector also carried a neo-resistance gene, 
therefore, stable transfectants were selected in G418. 
Upon comparison of the src-transformed cells trans- 
fected with vector alone and those transfected with 
PTPH1 cDNA, a flat adhesive morphology, charac- 
teristic of nontransformed cells, was evident in the 
latter case. In addition, transfection with PTPH1 
cDNA blocked focus formation, anchorage-indepen- 
dent growth, and tumor formation in nude mice. The 
level of cellular phosphotyrosine was also reduced in 
these cells relative to those displaying the transformed 
morphology. Such studies should provide a starting 
point from which to pursue the role of tyrosine phos- 
phorylation in transformation i duced by src. PTPH1 
may prove to be a powerful probe to define precisely 
the key substrates of src involved in generating the 
transformed phenotype and to help identify the pro- 
teins phosphorylated on tyrosyl residues in the altera- 
tions in the cytoskeleton that accompany the normal 
course of the cell cycle. In view of the structural diversi- 
ty observed within the known repertoire of PTPases, 
one might anticipate functional specificity in vivo. Al- 
though specificity among the PTPases may also be a 
feature of their capacity to revert transformation i - 
duced by particular PTKs, this hypothesis remains to be 
tested exhaustively. 
PERSPECTIVES 
One area in which rapid progress is anticipated is the 
development of the concept that the PTPases may func- 
tion as antioncogenes. The increase in tyrosine phos- 
phorylation observed in some transformed cells may be 
achieved by inactivation of a PTPase rather than by 
activation of a PTK. Treatment of NRK-1 ceils with 
vanadate, which among other actions is an inhibitor of 
PTPases, enhanced the level of cellular phospho- 
tyrosine and led to the production of a transformed 
morphology (Klarlund 1985). Examination of the chro- 
mosomal localization of various PTPase genes is high- 
lighting some interesting correlations with sites of ab- 
normality associated with certain neoplasias. Most no- 
tably, the gene for receptor PTPase3, maps to a region 
of human chromosome 3, 3p21, that is frequently de- 
leted in renal cell and lung cell carcinomas. In three of 
the lung tumors, one RPTPy allele was lost whereas 
flanking loci were not deleted (LaForgia et al. 1991). 
Similar studies with the gene for PTP1B also appear 
interesting (Brown-Shimer et al. 1990). 
How many PTPases are there? Despite the recent 
explosion in the number of members of the family to be 
identified, it seems safe to assume that we are only 
viewing the tip of a very large iceberg. It is likely that 
the PTPases will rival the family of PTKs in their 
structural diversity and complexity. Using PCR pro- 
tocols, 27 PTPase-related sequences were identified in 
the protochordate, Styela plicata (Matthews et al. 
1991). Furthermore, we have identified 15 distinct se- 
quences in a Xenopus oocyte cDNA library and have 
confirmed the presence of mRNA for each species (Q. 
Yang and N.K. Tonks, in prep.). Obviously, there 
exists considerable complexity in the pattern of expres- 
sion of PTPases even within a single cell. It is hoped 
that the characterization f these species will lead us to 
a more sophisticated understanding of the physiological 
role of tyrosine phosphorylation. 
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